Scholar Rock Holding Corp. (SRRK)
42.19
-0.01
(-0.02%)
USD |
NASDAQ |
Oct 09, 16:00
42.19
0.00 (0.00%)
After-Hours: 17:37
Scholar Rock Enterprise Value : 4.843B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 4.843B |
| October 07, 2026 | 4.843B |
| October 06, 2026 | 4.874B |
| October 05, 2026 | 4.989B |
| October 02, 2026 | 5.404B |
| October 01, 2026 | 5.325B |
| September 30, 2026 | 5.587B |
| September 29, 2026 | 5.518B |
| September 28, 2026 | 5.686B |
| September 25, 2026 | 5.625B |
| September 24, 2026 | 5.623B |
| September 23, 2026 | 5.774B |
| September 22, 2026 | 5.936B |
| September 21, 2026 | 5.568B |
| September 18, 2026 | 5.384B |
| September 17, 2026 | 5.673B |
| September 16, 2026 | 5.715B |
| September 15, 2026 | 5.792B |
| September 14, 2026 | 6.017B |
| September 11, 2026 | 6.450B |
| September 10, 2026 | 6.481B |
| September 09, 2026 | 6.354B |
| September 08, 2026 | 6.694B |
| September 04, 2026 | 6.440B |
| September 03, 2026 | 6.514B |
| Date | Value |
|---|---|
| September 02, 2026 | 6.534B |
| September 01, 2026 | 6.508B |
| August 31, 2026 | 6.619B |
| August 28, 2026 | 6.740B |
| August 27, 2026 | 6.918B |
| August 26, 2026 | 7.013B |
| August 25, 2026 | 6.795B |
| August 24, 2026 | 6.789B |
| August 21, 2026 | 6.582B |
| August 20, 2026 | 6.430B |
| August 19, 2026 | 6.583B |
| August 18, 2026 | 6.366B |
| August 17, 2026 | 6.041B |
| August 14, 2026 | 6.098B |
| August 13, 2026 | 6.164B |
| August 12, 2026 | 6.256B |
| August 11, 2026 | 6.043B |
| August 10, 2026 | 6.022B |
| August 07, 2026 | 6.147B |
| August 06, 2026 | 6.113B |
| August 05, 2026 | 5.533B |
| August 04, 2026 | 5.523B |
| August 03, 2026 | 5.287B |
| July 31, 2026 | 5.463B |
| July 30, 2026 | 5.669B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 585.98M |
| Amgen, Inc. | 263.58B |
| BioCryst Pharmaceuticals, Inc. | 2.600B |
| Imunon, Inc. | 5.973M |
| Curis, Inc. | -3.190M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -109.90M |
| Total Expenses (Quarterly) | 109.90M |
| EPS Diluted (Quarterly) | -0.8414 |
| Earnings Yield | -8.18% |
| Normalized Earnings Yield | -8.137 |